Gene: STK11
Official Full Name: serine/threonine kinase 11provided by HGNC
Gene Summary: The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00980 | STK11 Knockout cell line (HCT 116) | Human | STK11 | Negative | Online Inquiry | |
KO10141 | STK11 Knockout cell line (HeLa) | Human | STK11 | 1:3~1:6 | Negative | Online Inquiry |
KO10142 | STK11 Knockout cell line (HEK293) | Human | STK11 | 1:3~1:6 | Negative | Online Inquiry |
KO10143 | STK11 Knockout cell line (A549) | Human | STK11 | 1:3~1:4 | Negative | Online Inquiry |
STK11 Gene Knockout Cell Lines are genetically modified cell lines that have undergone targeted disruption of the serine/threonine kinase 11 (STK11) gene, also known as LKB1. This pivotal gene is a critical regulator of cellular metabolism and growth, primarily functioning as a tumor suppressor by activating the AMPK pathway and regulating energy homeostasis. The mechanisms facilitated by STK11 include modulation of cellular stress responses and maintenance of cell cycle control, thereby playing a significant role in tumorigenesis, particularly in cancers like lung cancer and Peutz-Jeghers syndrome.
The scientific importance of STK11 Gene Knockout Cell Lines lies in their ability to serve as valuable tools for investigating the role of STK11 in cancer biology and metabolism. They provide researchers with a platform to elucidate the molecular mechanisms underlying STK11-related pathologies, enabling studies on cell growth, differentiation, and response to therapeutic agents in a controlled environment. Furthermore, these cell lines are invaluable in drug development programs aimed at targeting energy metabolism and exploring potential therapeutic interventions.
One of the significant advantages of using STK11 Gene Knockout Cell Lines is their specificity and reliability. Unlike alternative models, such as shRNA or CRISPR interference systems, which may offer transient and incomplete knockdown effects, these knockout cell lines provide a consistent and stable genetic alteration. This stability ensures reproducibility in experimental results, thereby enhancing the reliability of findings.
For researchers and clinicians focused on cancer biology or metabolic disorders, STK11 Gene Knockout Cell Lines present an exceptional opportunity to streamline investigations into the therapeutic implications of STK11 disruption. By leveraging these unique cellular models, users can advance their studies with greater confidence and precision. Our company prides itself on providing high-quality biological products developed through rigorous research and industry expertise, ensuring that researchers have access to cutting-edge tools that facilitate groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.